The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis

被引:32
作者
Aussy, Audrey [1 ]
Freret, Manuel [1 ]
Gallay, Laure [2 ]
Bessis, Didier [3 ,4 ]
Vincent, Thierry [3 ,5 ]
Jullien, Denis [2 ,6 ]
Drouot, Laurent [1 ]
Jouen, Fabienne [1 ]
Joly, Pascal [1 ]
Marie, Isabelle [1 ]
Meyer, Alain [7 ,8 ]
Sibilia, Jean [7 ,8 ]
Bader-Meunier, Brigitte [9 ]
Hachulla, Eric [10 ]
Hamidou, Mohammed [11 ]
Hue, Sophie [12 ]
Charuel, Jean-Luc [13 ]
Fabien, Nicole [2 ]
Viailly, Pierre-Julien [14 ]
Allenbach, Yves [15 ]
Benveniste, Olivier [15 ]
Cordel, Nadege [1 ,16 ,17 ]
Boyer, Olivier [1 ]
Amoura, Zahir
Aouizerate, Jessie
Authier, Francois-Jerome
Benhamou, Ygal
Benichou, Jacques
Cherqaoui, Bilade
Chosidow, Olivier
Debarbieux, Sebastien
Fardet, Laurence
Graveleau, Julie
Kahn, Jean-Emmanuel
Langlois, Vincent
Levesque, Herve
Martin, Jerome
Martis, Nihal
Masseau, Agathe
Musset, Lucile
Neel, Antoine
Queyrel-Moranne, Viviane
Terrier, Benjamin
Vinzio, Stephan
机构
[1] Univ Rouen, Normandy Univ, Rouen Univ Hosp, INSERM U1234, Rouen, France
[2] Edouard Herriot Univ Hosp, Lyon, France
[3] St Eloi Hosp, Montpellier, France
[4] Montpellier Univ Hosp, INSERM U1051, Montpellier, France
[5] Montpellier Univ Hosp, Montpellier, France
[6] Lyon Univ, Lyon, France
[7] Strasbourg Univ Hosp, Strasbourg, France
[8] Ctr Reference Malad Autoimmunes Rares, Strasbourg, France
[9] Necker Univ Hosp, AP HP, Paris, France
[10] Univ Lille, Hosp Claude Huriez, European Reference Network Connect Tissue & Muscu, Lille, France
[11] Hotel Dieu & CHU Nantes, Nantes, France
[12] Henri Mondor Hosp, AP HP, Creteil, France
[13] Pitie Salpetriere Univ Hosp, AP HP, Paris, France
[14] Univ Rouen, Normandy Univ, INSERM U1245, Rouen, France
[15] Pitie Salpetriere Univ Hosp, AP HP, Ctr Reference Malad Neuromusculaires, DHU i2B,INSERM UMRS 974, Paris, France
[16] French West Indies Univ, Pointe A Pitre, Guadeloupe, France
[17] Pointe A Pitre Univ Hosp, Pointe A Pitre, Guadeloupe, France
关键词
IDIOPATHIC INFLAMMATORY MYOPATHIES; CLASSIFICATION CRITERIA; SUBCLASS DISTRIBUTION; CLINICAL-FEATURES; REVISED CRITERIA; ANTIBODIES; MYOSITIS; ASSOCIATION; MALIGNANCY; POLYMYOSITIS;
D O I
10.1002/art.40895
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Anti-transcription intermediary factor 1 gamma (anti-TIF1 gamma) antibodies are the main predictors of cancer in dermatomyositis (DM). Yet, a substantial proportion of anti-TIF1 gamma-positive DM patients do not develop cancer. This study was undertaken to identify biomarkers to better evaluate the risk of cancer and mortality in DM. Methods This multicenter study was conducted in adult anti-TIF1 gamma-positive DM patients from August 2013 to August 2017. Anti-TIF1 gamma autoantibody levels and IgG subclasses were identified using a newly developed quantitative immunoassay. Age, sex, DM signs and activity, malignancy, and creatine kinase (CK) level were recorded. Risk factors were determined by univariate and multivariate analysis according to a Cox proportional hazards regression model. Results Among the 51 adult patients enrolled (mean +/- SD age 61 +/- 17 years; ratio of men to women 0.65), 40 (78%) had cancer and 21 (41%) died, with a mean +/- SD survival time of 10 +/- 6 months. Detection of anti-TIF1 gamma IgG2 was significantly associated with mortality (P = 0.0011) and occurrence of cancer during follow-up (P < 0.0001), with a 100% positive predictive value for cancer when the mean fluorescence intensity of anti-TIF1 gamma IgG2 was >385. None of the patients developed cancer after 24 months of follow-up. Univariate survival analyses showed that mortality was also associated with age >60 years (P = 0.0003), active DM (P = 0.0042), cancer (P = 0.0031), male sex (P = 0.011), and CK level >1,084 units/liter (P = 0.005). Multivariate analysis revealed that age >60 years (P = 0.015) and the presence of anti-TIF1 gamma IgG2 (P = 0.048) were independently associated with mortality. Conclusion Our findings indicate that anti-TIF1 gamma IgG2 is a potential new biomarker of cancer that should be helpful in identifying the risk of mortality in anti-TIF1 gamma-positive DM patients.
引用
收藏
页码:1360 / 1370
页数:11
相关论文
共 59 条
  • [1] Malignancy in Myositis
    Abou Zahr, Zaki
    Baer, Alan N.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (03) : 208 - 215
  • [2] Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab
    Aggarwal, Rohit
    Oddis, Chester V.
    Goudeau, Danielle
    Koontz, Diane
    Qi, Zengbiao
    Reed, Ann M.
    Ascherman, Dana P.
    Levesque, Marc C.
    [J]. RHEUMATOLOGY, 2016, 55 (06) : 991 - 999
  • [3] András C, 2008, J RHEUMATOL, V35, P438
  • [4] Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change
    Anyanwu, C. O.
    Fiorentino, D. F.
    Chung, L.
    Dzuong, C.
    Wang, Y.
    Okawa, J.
    Carr, K.
    Propert, K. J.
    Werth, V. P.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (04) : 969 - 974
  • [5] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [6] Dermatomyositis and immune-Mediated Necrotizing Myopathies: A window on Autoimmunity and Cancer
    Aussy, Audrey
    Boyer, Olivier
    Cordel, Nadege
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [7] Advances in serological diagnostics of inflammatory myopathies
    Benveniste, Olivier
    Stenzel, Werner
    Allenbach, Yves
    [J]. CURRENT OPINION IN NEUROLOGY, 2016, 29 (05) : 662 - 673
  • [8] Correlation of Anti-Signal Recognition Particle Autoantibody Levels With Creatine Kinase Activity in Patients With Necrotizing Myopathy
    Benveniste, Olivier
    Drouot, Laurent
    Jouen, Fabienne
    Charuel, Jean-Luc
    Bloch-Queyrat, Coralie
    Behin, Anthony
    Amoura, Zahir
    Marie, Isabelle
    Guiguet, Marguerite
    Eymard, Bruno
    Gilbert, Daniele
    Tron, Francois
    Herson, Serge
    Musset, Lucile
    Boyer, Olivier
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1961 - 1971
  • [9] Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients
    Best, M.
    Jachiet, M.
    Molinari, N.
    Manna, F.
    Girard, C.
    Pallure, V.
    Cosnes, A.
    Lipsker, D.
    Hubiche, T.
    Schmutz, J. -L.
    Le Corre, Y.
    Cordel, N.
    Dandurand, M.
    Dereure, O.
    Guillot, B.
    Du-Thanh, A.
    Livideanu, C. Bulai
    Chasset, F.
    Bouaziz, J. -D.
    Frances, C.
    Bengoufa, D.
    Vincent, T.
    Bessis, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : 1164 - 1172
  • [10] Myositis-specific autoantibodies: an important tool to support diagnosis of myositis
    Betteridge, Z.
    McHugh, N.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2016, 280 (01) : 8 - 23